Oftalmika Sp. z o.o.

At Oftalmika Sp. z o.o. in Bydgoszcz, the main focus is on eye diseases such as diabetic macular edema, age-related macular degeneration, diabetic retinopathy, glaucoma, and ocular hypertension. The studies are designed to assess new treatments, compare them with established therapies, and support better visual outcomes for people with retinal and optic nerve conditions.

• Research in diabetic macular edema and neovascular age-related macular degeneration is evaluating whether new eye treatments can improve vision as effectively as current standards.
• Several trials in geographic atrophy and dry AMD are testing approaches aimed at slowing lesion growth and preserving sight.
• Studies in choroidal neovascularization, retinal vein occlusion, and uveitic macular edema are examining the effectiveness of therapies for retinal swelling and vision loss.
• Work in open-angle glaucoma and ocular hypertension is focused on improving pressure control and long-term eye safety.

Overall, the site contributes to a broad ophthalmology research portfolio, with an emphasis on comparing treatment effectiveness, protecting vision, and extending the safety profile of promising eye therapies.

The site also conducts research in immune system diseases, especially atopic dermatitis and hidradenitis suppurativa. These studies aim to relieve symptoms, improve disease control, and help identify better options for people living with chronic inflammatory conditions.

• Trials in atopic dermatitis are exploring treatment adjustments to improve skin clearance and symptom relief.
• Research in hidradenitis suppurativa is evaluating a new therapy intended to reduce signs and symptoms of this painful inflammatory skin disorder.

This area reflects a focus on inflammatory disease management, with attention to both effectiveness and longer-term tolerability.

In the field of skin and connective tissue diseases, the clinical trials at this Polish research site include conditions with significant impact on daily comfort and quality of life, such as atopic dermatitis and hidradenitis suppurativa. The research is centered on testing therapies that may better control inflammation and reduce persistent skin symptoms.

• Studies are assessing whether new treatment strategies can improve control of atopic dermatitis in people with moderate to severe disease.
• Work in hidradenitis suppurativa is aimed at easing painful flares and improving overall disease burden.

Together, these trials support ongoing efforts to advance care for chronic dermatologic conditions through more effective and patient-friendly treatment options.